JOHN SATTERFIELD FORDTRAN, MD
Osteopathic Medicine in Dallas, TX
License number
Texas C6625
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
3500 Gaston Ave Jonsson Hospital SUITE 500, Dallas, TX 75246
Phone
(214) 820-2672
(214) 820-4837 (Fax)
(214) 820-4837 (Fax)
Personal information
See more information about JOHN SATTERFIELD FORDTRAN at radaris.comName
Address
Phone
3508 Hanover St, Dallas, TX 75225
Dallas, TX
10438 High Hollows Dr, Dallas, TX 75230
3408 Hanouer, Dallas, TX 75225
3408 Hanover St, Dallas, TX 75225
Professional information
Dr. John S Fordtran, Dallas TX - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
3500 Gaston Ave SUITE 500, Dallas 75246
(214) 820-2672 (Phone), (214) 820-4837 (Fax)
(214) 820-2672 (Phone), (214) 820-4837 (Fax)
Languages:
English
Hospitals:
3500 Gaston Ave SUITE 500, Dallas 75246
Baylor University Medical Center at Dallas
3500 Gaston Ave, Dallas 75246
Baylor University Medical Center at Dallas
3500 Gaston Ave, Dallas 75246
Education:
Medical School
Tulane University of Louisiana
Graduated: 1956
Tulane University of Louisiana
Graduated: 1956
John Satterfield Fordtran, Dallas TX
Specialties:
Internal Medicine, Gastroenterology
Work:
Baylor University Medical Center
3500 Gaston Ave, Dallas, TX 75246
3500 Gaston Ave, Dallas, TX 75246
Education:
Tulane University (1956)
Methods And Compositions For Treatment Of Ion Imbalances
US Patent:
7776319, Aug 17, 2010
Filed:
Mar 30, 2005
Appl. No.:
11/095760
Inventors:
Robert Alpern - Woodbridge CT, US
Jerry Buysse - Los Altos CA, US
Han Ting Chang - Livermore CA, US
Dominique Charmot - Campbell CA, US
Michael James Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Gerrit Klaerner - San Jose CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Campbell CA, US
Futian Liu - Mountain View CA, US
Jun Shao - Fremont CA, US
Jerry Buysse - Los Altos CA, US
Han Ting Chang - Livermore CA, US
Dominique Charmot - Campbell CA, US
Michael James Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Gerrit Klaerner - San Jose CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Campbell CA, US
Futian Liu - Mountain View CA, US
Jun Shao - Fremont CA, US
Assignee:
Relypsa, Inc. - Santa Clara CA
International Classification:
A61K 31/74, A61K 31/765, A61K 31/785, A61K 9/14, A61P 3/12, A61P 9/12, A61P 13/12
US Classification:
424 781, 424490, 424497, 514838, 514869, 514870, 514893
Abstract:
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
Anion-Binding Polymers And Uses Thereof
US Patent:
7718746, May 18, 2010
Filed:
May 22, 2009
Appl. No.:
12/471220
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - San Jose CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - San Jose CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C08F 26/06, C07C 211/11
US Classification:
526310, 526258, 525334, 525374, 525526, 424 7806, 424 7811, 424 7812, 424 7816, 524612, 521 36, 564511, 564512
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.
Pharmaceutical Compositions Comprising Cross-Linked Small Molecule Amine Polymers
US Patent:
7608674, Oct 27, 2009
Filed:
Nov 3, 2004
Appl. No.:
10/980991
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - Los Gatos CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han-Ting Chang - Livermore CA, US
Florence Roger - Preverenges, CH
Gerrit Klaerner - Los Gatos CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C11D 1/00, C08F 26/06
US Classification:
526310, 526258, 525334, 424 7806, 424 7811, 424 7812, 424 7816
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.
Ion Binding Compositions
US Patent:
8282960, Oct 9, 2012
Filed:
Mar 30, 2004
Appl. No.:
10/813872
Inventors:
Dominique Charmot - Campbell CA, US
John Fordtran - Dallas TX, US
Han Ting Chang - Livermore CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Santa Clara CA, US
Gerrit Klaerner - San Jose CA, US
John Fordtran - Dallas TX, US
Han Ting Chang - Livermore CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Santa Clara CA, US
Gerrit Klaerner - San Jose CA, US
Assignee:
Relypsa, Inc. - Santa Clara CA
International Classification:
A61K 9/14, A61K 9/54
US Classification:
424490, 424489, 424497, 424501
Abstract:
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
Treatment Of Hyperphosphatemia Using Crosslinked Small Molecule Amine Polymers
US Patent:
7589238, Sep 15, 2009
Filed:
Aug 17, 2006
Appl. No.:
11/465444
Inventors:
Eric Connor - Los Gatos CA, US
Dominique Charmot - Campbell CA, US
Han Ting Chang - Livermore CA, US
Florence Roger - Santa Clara CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Dominique Charmot - Campbell CA, US
Han Ting Chang - Livermore CA, US
Florence Roger - Santa Clara CA, US
Son Hoai Nguyen - San Jose CA, US
Jonathan Mills - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Angela Lee - San Jose CA, US
Deidre Madsen - Sunnyvale CA, US
Jun Shao - Fremont CA, US
Michael J. Cope - Berkeley CA, US
John Fordtran - Dallas TX, US
Assignee:
Ilypsa, Inc. - Thousand Oaks CA
International Classification:
C07C 211/11, C08G 2/00
US Classification:
564511, 564512, 5147723, 525526, 521 36
Abstract:
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.
Ion Binding Compositions
US Patent:
7429394, Sep 30, 2008
Filed:
Mar 30, 2005
Appl. No.:
11/095918
Inventors:
Dominique Charmot - Campbell CA, US
John Fordtran - Dallas TX, US
Han Ting Chang - Livermore CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Santa Clara CA, US
Gerrit Klaerner - San Jose CA, US
John Fordtran - Dallas TX, US
Han Ting Chang - Livermore CA, US
Eric Connor - Los Gatos CA, US
Mingjun Liu - Santa Clara CA, US
Gerrit Klaerner - San Jose CA, US
Assignee:
Relypsa, Inc. - Santa Clara CA
International Classification:
A61K 9/14, A61K 9/16
US Classification:
424490, 424489
Abstract:
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
Ion Binding Polymers And Uses Thereof
US Patent:
8216560, Jul 10, 2012
Filed:
Mar 26, 2008
Appl. No.:
12/055726
Inventors:
Dominique Charmot - Campbell CA, US
Han Ting Chang - Livermore CA, US
John Fordtran - Dallas TX, US
Gerrit Klaerner - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Robert Alpern - Dallas TX, US
Mingjun Liu - Campbell CA, US
Han Ting Chang - Livermore CA, US
John Fordtran - Dallas TX, US
Gerrit Klaerner - San Jose CA, US
Jerry M. Buysse - Los Altos CA, US
Robert Alpern - Dallas TX, US
Mingjun Liu - Campbell CA, US
Assignee:
Relypsa, Inc. - Santa Clara CA
International Classification:
A61K 31/74
US Classification:
424 7808
Abstract:
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.
Phosphorus Binder
US Patent:
4870105, Sep 26, 1989
Filed:
Apr 7, 1987
Appl. No.:
7/035341
Inventors:
John S. Fordtran - Dallas TX
Assignee:
Braintree Laboratories, Inc. - Braintree MA
International Classification:
A61K 3119
US Classification:
514557
Abstract:
A composition for oral administration to an individual for the purpose of inhibiting gastrointestinal absorption of phosphorous, which includes calcium acetate. A method of inhibiting gastrointestinal absorption of phosphorous, comprising administering orally the composition, preferably close in time to food and beverage consumption.